UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

PBPK models for the prediction of in vivo performance of oral dosage forms

European journal of pharmaceutical sciences, 2014-06, Vol.57 (SI), p.300-321

2014

Volltextzugriff (PDF)

Prediction of intestinal first-pass drug metabolism

Current drug metabolism, 2007-10, Vol.8 (7), p.676-684

2007

Volltextzugriff (PDF)

Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data

Drug metabolism and pharmacokinetics, 2016-06, Vol.31 (3), p.224-233

2016

Volltextzugriff (PDF)

Biopharmaceutic IVIVE—Mechanistic Modeling of Single- and Two-Phase In Vitro Experiments to Obtain Drug-Specific Parameters for Incorporation Into PBPK Models

Journal of pharmaceutical sciences, 2019-04, Vol.108 (4), p.1604-1618

2019

Volltextzugriff (PDF)

The Simcyp® Population-based ADME Simulator

Expert opinion on drug metabolism & toxicology, 2009-02, Vol.5 (2), p.211-223

2009

Volltextzugriff (PDF)

Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model

Drug metabolism and disposition, 2016-06, Vol.44 (6), p.821-832

2016

Volltextzugriff (PDF)

Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs

The AAPS journal, 2017-07, Vol.19 (4), p.1205-1217

2017

Volltextzugriff (PDF)

Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: A case study using the BCS/BDDCS Class II drug nifedipine

European journal of pharmaceutical sciences, 2014-06, Vol.57, p.240-249

2014

Volltextzugriff (PDF)

Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process

The AAPS journal, 2016-09, Vol.18 (5), p.1144-1158

2016

Volltextzugriff (PDF)

Application of permeability-limited physiologically-based pharmacokinetic models: Part I–digoxin pharmacokinetics incorporating P-glycoprotein-mediated efflux

Journal of pharmaceutical sciences, 2013-09, Vol.102 (9), p.3145-3160

2013

Volltextzugriff (PDF)

A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution

Journal of pharmacy and pharmacology, 2012-07, Vol.64 (7), p.1008-1024

2012

Volltextzugriff (PDF)

1 – 11 von 11

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR Archive Collection A-Z Listing

ThemaAlgorithms

ThemaAdministration, Oral

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(11)

Sprache

Englisch
(11)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(11)
Life Sciences & Biomedicine
(10)
Pharmacology & Pharmacy
(10)
Science & Technology
(10)
Models, Biological
(9)
Computer Simulation
(5)
Animals
(4)
Chemistry, Pharmaceutical
(4)
Intestinal Absorption
(4)
Permeability
(4)
Pharmaceutical Preparations - Metabolism
(4)
Pharmacokinetics
(4)
Solubility
(4)
Biopharmaceutics - Methods
(3)
In Vitro-In Vivo Extrapolation
(3)
Pbpk
(3)
Pharmaceutical Preparations - Administration & Dosage
(3)
Adolescent
(2)
Adult
(2)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PBPK models for the prediction of in vivo performance of oral dosage forms

Prediction of intestinal first-pass drug metabolism

Development of a permeability-limited model of the human brain and cerebrospinal fluid (CSF) to integrate known physiological and biological knowledge: Estimating time varying CSF drug concentrations and their variability using in vitro data

Biopharmaceutic IVIVE—Mechanistic Modeling of Single- and Two-Phase In Vitro Experiments to Obtain Drug-Specific Parameters for Incorporation Into PBPK Models

The Simcyp® Population-based ADME Simulator

Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic Model

Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs

Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: A case study using the BCS/BDDCS Class II drug nifedipine

Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process

Application of permeability-limited physiologically-based pharmacokinetic models: Part I–digoxin pharmacokinetics incorporating P-glycoprotein-mediated efflux

A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution

Aktive Filter

Suchergebnisse filtern